ClinicalThought Commentary


Program Content


  • CRS in MM
    Our Thoughts on Cytokine Release Syndrome With BCMA-Targeted Therapies for Relapsed/Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 19, 2023


cover img faculity

Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP

Clinical Oncology Pharmacy Manager
Atrium Health Levine Cancer Institute
Charlotte, North Carolina

cover img faculity

Victoria Nachar, PharmD, BCOP

Clinical Pharmacist Specialist, Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan

Provided by

ProCE Banner


Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb


Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner